References
- Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis/motor neuron disease. ALS 2003; 4: 191–206
- Solaroglu I, Cahill J, Jadhav V. A novel neuroprotectant G-CSF. Stroke 2006; 37: 1123–8
- Hubel K, Engert A. Clinical applications of G-CSF: an update and summary. Ann Hematol 2003; 82: 207–13
- Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, et al. Intrathecal up-regulation of G-CSF and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006; 65: 816–25
- Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, et al. Three- to six-year follow-up of normal donors who received recombinant human G-CSF. Bone Marrow Transplant 2000; 25: 85–9
- Shapira MY, Kaspler P, Samuel S, Shoshan S, Or R. G-CSF does not induce long-term DNA instability in healthy peripheral blood stem cell donors. Am J Hematol 2003; 73: 33–6